Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

BACKGROUND: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established in clinical trials for this group of biologic agent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs Context
Autores principales: Fieldhouse, Keira A, Ukaibe, Samantha, Crowley, Erika L, Khanna, Reena, O’Toole, Ashley, Gooderham, Melinda J
Formato: Artigo
Lenguaje:Inglês
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185907/
https://ncbi.nlm.nih.gov/pubmed/32362930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-2-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares